Location History:
- Mountainside, NJ (US) (2019)
- Astoria, NY (US) (2015 - 2023)
Company Filing History:
Years Active: 2015-2023
Title: Inventor Spotlight: Tianle Yang Redanz
Introduction: Tianle Yang Redanz is a renowned inventor based in Astoria, NY, known for his significant contributions to the field of biochemistry and pharmacology. With a total of six patents to his name, he continues to innovate in the realm of nicotinoyl ribosides and their applications in enhancing cellular health.
Latest Patents: One of Tianle's most notable inventions is centered around "Nicotinoyl riboside compositions and methods of use." This invention explores various compositions of nicotinoyl ribosides and nicotinamide riboside derivatives, with a focus on the methods of making these compounds. His work highlights the development of pharmaceutical compositions and nutritional supplements that utilize nicotinoyl riboside. Moreover, it demonstrates the potential of these compounds to increase intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues, ultimately improving cell and tissue survival.
Career Highlights: Tianle Yang Redanz has built a distinguished career as a researcher and inventor at Cornell University. His dedication and innovative spirit have allowed him to accumulate several patents that pave the way for advancements in health-related applications of nicotinoyl ribosides.
Collaborations: Working alongside him is his esteemed coworker, Anthony A. Sauve. Together, they collaborate on research projects that further explore the benefits and applications of nicotinoyl ribosides, contributing significantly to the body of knowledge in their field.
Conclusion: Tianle Yang Redanz stands out as a leading inventor in the domain of biochemistry, particularly through his work with nicotinoyl ribosides. His innovative patents not only reflect his expertise but also hold promise for future advancements in health and wellness. With collaborations that enhance his research, Yang continues to be a vital asset to the scientific community.